Exactus Inc. to Showcase Upcoming Product Portfolio at USA CBD Expo 2019
Stop by Booth 102 – 105 to sit down with the Exactus team and learn about our products
DELRAY BEACH, Fla., July 29, 2019 (GLOBE NEWSWIRE) — Exactus Inc. (OTCQB: EXDI) – (the “Company”), a healthcare company pursuing opportunities in hemp derived cannabidiol (CBD) products, today announced it will be showcased at the upcoming USA CBD Expo in Miami Beach, Florida from August 2nd to August 4th.
The USA CBD Expo aims to bring together hundreds of leading CBD brands and products from vape manufacturers, holistic and health food producers, pet care brands and a wide variety of other brands from around the world.
Exactus will have a 10’x40′ booth located at 102-105 on the showroom floor and will also be catering a premium hosted bar on the first day of the event. During the event, attendees will be able to see and sample our latest CBD products, take advantage of special promotions and discounts, participate in product demonstrations and educational sessions of CBD, and learn about the benefits of Cannabinoids and how Exactus can be your one-stop solution for all your CBD needs.
In addition, attendees will be able to watch a series of films that show the progression of Exactus farms up to the current state of growth on a 20 ft screen. Emiliano Aloi, the company’s President, said, “This industry is so new that the actual consumer has little idea of what a professionally-operated farm looks like and where their products come from. We go to great lengths to create video content that educates the consumers on how the health of the plant translates to a healthier product for their bodies”.
To learn more about Exactus, Inc., visit the website at www.exactusinc.com.
Exactus Inc. is a company advocated to reintegrating the hemp supply chain into the world’s mainstream commercial markets, including the farming, development and distribution of hemp-derived Cannabidiol products, which is more commonly referred to as CBD, and is one of the non-psychoactive Cannabinoids found in the plant. Industrial hemp is a type of Cannabis plant containing less than 0.3% THC (tetrahydrocannabinol), which is the psychoactive component of the Cannabis plant. Industrial hemp is cultivated for the plant’s seed, fiber, and extracts. After 40 years of prohibition, the Agricultural Improvement Act of 2018, known as the 2018 Farm Bill, legalized hemp on the federal level as an agricultural crop. Hemp production will be regulated by the United States Department of Agriculture (USDA) and the states. As a result, Hemp has generally been removed from the Controlled Substances Act (CSA) and the Drug Enforcement Administration (DEA). A potential risk of growing hemp in the United States is that the entire crop must be destroyed if it tests at a THC percentage greater than 0.3%.
For more information about Exactus: www.exactusinc.com.
Investing in our securities involves a high degree of risk. Before making an investment decision, you should carefully consider the risks, uncertainties and forward-looking statements described under “Risk Factors” in Item 1A of our most recent Form 10-K for the fiscal year ended December 31, 2018 filed with the Securities and Exchange Commission (the “SEC”) on March 29, 2019 and under the heading “Risk Factors” in our Current Report on Form 8-K filed with the SEC on January 14, 2019, and in other periodic and current reports we file with the SEC. If any of these risks were to occur, our business, financial condition, or results of operations would likely suffer. In that event, the value of our securities could decline, and you could lose part or all of your investment. The risks and uncertainties we describe are not the only ones facing us. Additional risks not presently known to us or that we currently deem immaterial may also impair our business operations. In addition, our past financial performance may not be a reliable indicator of future performance, and historical trends should not be used to anticipate results in the future. See “Safe Harbor” below.
Safe Harbor – Forward-Looking Statements
The information provided in this press release may include forward-looking statements relating to future events or the future financial performance of the Company. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Words such as “anticipates,” “plans,” “expects,” “intends,” “will,” “potential,” “hope” and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon current expectations of the Company and involve assumptions that may never materialize or may prove to be incorrect. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties. Detailed information regarding factors that may cause actual results to differ materially from the results expressed or implied by statements in this press release relating to the Company may be found in the Company’s periodic and current filings with the SEC, including the factors described in the sections entitled “Risk Factors”, copies of which may be obtained from the SEC’s website at www.sec.gov. Any forward-looking statement speaks only as of the date on which such statement is made, and the Company does not intend to correct or update any forward-looking statement, whether as a result of new information, future events or otherwise.
Chief Strategy Officer
Source: Exactus, Inc.
Released July 29, 2019